CCL17 and non-small cell lung carcinoma: Furthermore, exploration of the correlation between CCL17 expression and key pathways in NSCLC patients (Figures 5E, F) revealed a positive correlation with pro-inflammatory pathways and a significant negative correlation with tumor proliferation pathways.